Notably, the conference appears to have beefed up security around the main venue – the Westin St. Francis Hotel – this year in light of the killing of Brian Thompson, the CEO of UnitedHealth Group's ...

Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue ...

ELI LILLY'S MOUNJARO IS MORE EFFECTIVE FOR WEIGHT ... after obesity treatments such as Ozempic and Wegovy, throughout New York City's subway system. FOX Business' Bre Stimson contributed to ...

The anti-obesity drug Zepbound made by Eli ... of New York, US, on Thursday, March 28, 2024. (Photographer: Shelby Knowles/Bloomberg) The anti-obesity drug Zepbound made by Eli Lilly & Co. could ...

(Bloomberg) -- Eli Lilly & Co.’s weight ... sales by the end of the decade. Lilly shares were little changed in trading before the market open in New York. In a pair of large sleep apnea studies ...

FILE PHOTO: An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/File Photo · REUTERS / Reuters JPMorgan analyst ...